Abnormal Liver Function Tests Due to Hepatotoxic Herbs

Herbal Supplements: Efficacy, Toxicity, Interactions with Western Drugs, and Effects on Clinical Laboratory Tests

Volumn , Issue , 2010, Pages 155-167

  Dasgupta, Amitava ^a   Hammett Stabler, Catherine A ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Abnormal liver function (LFTs) and use of herbal supplements; Abnormal liver function tests, with hepatotoxic herbs liver, removal of toxic compounds from body; Herbals and herbal products associated with hepatotoxicity

Indexed keywords

EID: 84886041372     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470910108.ch7     Document Type: Chapter

References (36)

1. Kawaguchi T, Harada M, Arimatsu H, et al. Severe hepatotoxicity associated with a N-nitrosofenfl uramine containing weight loss product. J Gastroenterol Hepatol 2004; 19: 349-50.
2. Jamieson DD, Duffield PH, Cheng D, Duffield AM. Composition of central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum). Arch Int Pharmacodyn 1989; 301: 66-80.
3. Whittaker P, Clark JJ, San RH, et al. Evaluation of commercial kava extracts and kava lactones standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells. Food Chem Toxicol 2008; 46: 168-74.
4. Anke J, Razman I. Phramcokinetic and pharmacodynamic drug interactions with kava (Piper methysticum Forst.). J Ethnopharmacol 2004; 93: 153-60.
5. Scherer J. Kava-kava extract in anxiety disorders: an outpatient observational study. Adv Ther 1998; 15: 261-69.
6. Li XZ, Razman I. Role of ethanol in kava hepatotoxicity. Phytochemistry 2010; 24: 475-80.
7. Denham A, McIntyre MA, Whitehouse J. Kava-the unfolding story: report on a work-in-progress. J Altern Complement Med 2002; 8: 237-63.
8. Clouatre DL. Kava kava: examining new reports of toxicity. Toxicol Lett 2004; 150: 85-96.
9. Escher M, Desmeules J. Hepatitis associated with kava, a herbal remedy. Br Med J 2001; 322: 139.
10. Kraft M, Spahn TW, Menzel J, et al. Fulminant liver failure after administration of the herbal antidepressant kava-kava. Dtsch Med Wochenschr 2001; 126: 970-2.
11. Jappe U, Frankle I, Reinhold D, Gollnick HP. Sebotrophic drug reaction resulting from kava-kava extract therapy; a new entity? J Am Acad Dermatol 1998; 38: 104-6.
12. Whitton PA, Lau A, Salisbury A, et al. Kava lactones and kava kava controversy. Phytochemistry 2003; 64: 673-9.
13. Teschke R, Genthner A, Wolf A. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava herbs mixtures. J Ethnopharmacology 2009; 123: 378-84.
14. Almedi JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam. Ann Intern Med 1996; 125: 940-1.
15. Alderman S, Kailas S, Goldfarb S, et al. Cholestatic hepatitis after ingestion of chaparral leaves: confi rmation by endoscopic retrograde cholangiopancreatography and liver biopsy. J Clin Gastroenterol 1994; 19: 242-7.
16. Sheikh NM, Philen RM, Love LA. Chaparral associated hepatotoxicity. Arch Intern Med 1997; 157: 913-9.
17. Stickel L, Seitz HK. The efficacy and safety of comfrey. Public Health Nutr 2000; 3 (4A): 501-8.
18. Yeong ML, Swinburn B, Kennedy M, Nicholson G. Hepatic veno-occlusive disease associated with comfrey ingestion. J Gastroenterol Hepatol 1990; 5: 211-4.
19. Ridker PM, Ohkuma S, McDermott WV, Trey C. Hepatic veno-occlusive disease associated with the consumption of pyrrolizidine containing dietary supplements. Gastroenterology 1985; 88: 1050-4.
20. Oberlies NH, Kim NC, Brine DR, et al. Analysis of herbal tea made from leaves of comfrey (Symphytum offi cinale): reduction of N-oxides results in order of magnitude increases in the measurable concentration of pyrrolizidine alkaloids. Public Health Nutr 2004; 7: 919-24.
21. Roulet M, Laurini R, Rivier L, Calame A. Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea. J Pediatr 1988; 112: 433-6.
22. Castot A, Larrey D. Hepatitis observed during a treatment with a drug or tea containing wild germander. Evaluation of 26 cases reported to the Regional Centers for Pharmacovigilance. Clin Biol 1992; 16: 916-99.
23. Laliberte L, Villeneuve JP. Hepatitis after use of germander, a herbal remedy. Can Med Assoc J 1996; 154: 1689-92.
24. Seeff LB. Herbal hepatotoxicity. Clin Liver Dis 2007; 11: 577-96.
25. Kouzi SA, McMurtry RJ, Nelson SD. Hepatotoxicity of germander (Teucrium chamaedrys L.) and one of its constituent neoclerodane diterpenes teucrin A in the mouse. Chem Res Toxicol 1994; 7: 850-6.
26. Poon WT, Chan TL, Lai CK, et al. Hepatitis induced by Teucrium viscidum. Clin Toxicol (Phila) 2008; 46: 819-22.
27. Favreau JT, Ryu ML, Braunstein G, et al. Severe hepatotoxicity associated with use of dietary supplement. Ann Intern Med 2002; 136: 590-5.
28. Chitturi S, Farrell GC. Hepatotoxic slimming aids and other herbal hepatotoxins. J Gastroenterol Hepatol 2008; 23: 355-73.
29. Hutchens AR. A handbook of Native American herbs. Boston: Shambhala Publications, 1992.
30. Nisbet BC, O'Connor RE. Black cohosh induced hepatitis. Del Med J 2007; 79: 441-4.
31. Anderson IB, Mullen WH, Meeker JE, et al. Pennyroyal toxicity: measurement of toxic metabolites levels in two cases and review of literature. Ann Intern Med 1996; 124: 726-34.
32. Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002; 177: 440-3.
33. Mahady GB, Low Dog T, Barrett ML, et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008; 15: 628-38.
34. Harvey J, Colin-Jones DG. Mistletoe hepatitis. Br Med J (Clin Res Ed) 1981; 282 (6259): 186-7.
35. Molinari M, Watt KD, Kruszyna T, et al. Acute liver failure induced by green tea extract: case report and review of literature. Liver Transpl 2006; 12: 1892-5.
36. Jorge OA, Jorge AD. Hepatotoxicity associated with the ingestion of Centella asiatica. Rev Esp Enferm Dig 2005; 97: 115-24.